Skip to main content
. 2019 Mar 1;11(1):e2019016. doi: 10.4084/MJHID.2019.016

Figure 4.

Figure 4

Differences in Area Under the Dose-Response Curve between anthracyclines. A 28.3% of patients samples showed >30% different potency among Idarubicin-Daunorubicin-Mitoxantrone Area Under the Dose-Response Curve (AUC).